Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 934605, 15 pages
http://dx.doi.org/10.1155/2014/934605
Review Article

Recent Trends of Polymer Mediated Liposomal Gene Delivery System

1Department of Physics, School of Basic and Applied Sciences, Galgotias University, Greater Noida 203201, India
2Department of Physics, Tokai University, Hiratsuka-Shi, Kanagawa 259-1292, Japan
3Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon 200704, Republic of Korea
4Medical Biotechnology Division, School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu 632014, India
5Department of Bioinformatics, School of Computer Sciences, Galgotias University, Greater Noida 203201, India

Received 9 May 2014; Revised 15 July 2014; Accepted 15 July 2014; Published 27 August 2014

Academic Editor: Nagendra K. Kaushik

Copyright © 2014 Shyamal Kumar Kundu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Tatum, “Molecular biology, nucleic acids, and the future of medicine,” Perspectives in Biology and Medicine, vol. 10, no. 1, pp. 19–32, 1966. View at Google Scholar · View at Scopus
  2. T. Friedmann, “Progress toward human gene therapy,” Science, vol. 244, no. 4910, pp. 1275–1281, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. P. L. Felgner and G. Rhodes, “Gene therapeutics,” Nature, vol. 349, no. 6307, pp. 351–352, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. R. C. Mulligan, “The basic science of gene therapy,” Science, vol. 260, no. 5110, pp. 926–932, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. A. D. Bangham, M. M. Standish, and J. C. Watkins, “Diffusion of univalent ions across the lamellae of swollen phospholipids.,” Journal of Molecular Biology, vol. 13, no. 1, pp. 238–252, 1965. View at Publisher · View at Google Scholar · View at Scopus
  6. L. D. Mayer, P. R. Cullis, and M. B. Bally, “The use of transmembrane pH gradient-driven drug encapsulation in the pharmacodynamic evaluation of liposomal doxorubicin,” Journal of Liposome Research, vol. 4, no. 1, pp. 529–553, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. D. D. Lasic, “Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo,” Journal of Controlled Release, vol. 48, no. 2-3, pp. 203–222, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Ulrich, “Biophysical aspects of using liposomes as delivery vehicles,” Bioscience Reports, vol. 22, no. 2, pp. 129–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Kidane, G. C. Lantz, S. Jo, and K. Park, “Surface modification with PEO-containing triblock copolymer for improved biocompatibility: in vitro and ex vivo studies,” Journal of Biomaterials Science, Polymer Edition, vol. 10, no. 10, pp. 1089–1105, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Monfardini and F. M. Veronese, “Stabilization of substances in circulation,” Bioconjugate Chemistry, vol. 9, no. 4, pp. 418–450, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. E. T. M. Dams, P. Laverman, W. J. G. Oyen et al., “Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes,” Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 3, pp. 1071–1079, 2000. View at Google Scholar · View at Scopus
  12. M. T. Peracchia, E. Fattal, D. Desmaële et al., “Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting,” Journal of Controlled Release, vol. 60, no. 1, pp. 121–128, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. C. Woodle, “Controlling liposome blood clearance by surface-grafted polymers,” Advanced Drug Delivery Reviews, vol. 32, no. 1-2, pp. 139–152, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. C. R. O'Riordan, A. Lachapelle, C. Delgado et al., “PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo,” Human Gene Therapy, vol. 10, no. 8, pp. 1349–1358, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Bhadra, S. Bhadra, P. Jain, and N. K. Jain, “Pegnology: a review of PEG-ylated systems,” Pharmazie, vol. 57, no. 1, pp. 5–29, 2002. View at Google Scholar · View at Scopus
  16. A. V. Kabanov and V. A. Kabanov, “Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects,” Advanced Drug Delivery Reviews, vol. 30, no. 1–3, pp. 49–60, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Lemieux, S. V. Vinogradov, C. L. Gebhart et al., “Block and graft copolymers and Nanogel(TM) copolymer networks for DNA delivery into cell,” Journal of Drug Targeting, vol. 8, no. 2, pp. 91–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Metselaar, P. Bruin, L. W. T. De Boer et al., “A novel family of L-amino acid-based biodegradable polymerlipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity,” Bioconjugate Chemistry, vol. 14, no. 6, pp. 1156–1164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Immordino, F. Dosio, and L. Cattel, “Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential,” International Journal of Nanomedicine, vol. 1, no. 3, pp. 297–315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. D. Bangham and R. W. Horne, “Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope,” Journal of Molecular Biology, vol. 8, no. 5, pp. 660–668, 1964. View at Publisher · View at Google Scholar · View at Scopus
  21. R. W. Horne, A. D. Bangham, and V. P. Whittaker, “Negatively stained lipoprotein membranes,” Nature, vol. 200, no. 4913, article 1340, 1963. View at Publisher · View at Google Scholar · View at Scopus
  22. A. D. Bangham and R. W. Horne, “Action of saponin on biological cell membranes,” Nature, vol. 196, no. 4858, pp. 952–953, 1962. View at Publisher · View at Google Scholar
  23. D.-G. Margineanu, “Equilibrium and non-equilibrium approaches in biomembrane thermodynamics,” Archives Internationales de Physiologie et de Biochimie, vol. 95, no. 5, pp. 381–422, 1987. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Svetina and B. Zeks, “Shape behavior of lipid vesicles as the basis of some cellular processes,” Anatomical Record, vol. 268, no. 3, pp. 215–225, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shimomura and T. Sawadaishi, “Bottom-up strategy of materials fabrication: a new trend in nanotechnology of soft materials,” Current Opinion in Colloid and Interface Science, vol. 6, no. 1, pp. 11–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. D. Houslay and K. K. Stanley, Eds., Dynamics of Biological Membranes, Wiley Interscience Publications, John Wiley & Sons, New York, NY, USA, 1982.
  27. S. K. Kundu, S. G. Choe, W. Yamamoto, R. Kita, and S. Yagihara, “Dielectric relaxation and dynamic light scattering study of liposome in the asqueous solution,” in Material Research Society Symposium Proceedings, vol. 1019, pp. FF04–FF08, 2007. View at Publisher · View at Google Scholar
  28. F. Szoka Jr. and D. Papahadjopoulos, “Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 9, pp. 4194–4198, 1978. View at Google Scholar · View at Scopus
  29. R. L. Shew and D. W. Deamer, “A novel method for encapsulation of macromolecules in liposomes,” Biochimica et Biophysica Acta: Biomembranes, vol. 816, no. 1, pp. 1–8, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. L. D. Mayer, M. B. Bally, and P. R. Cullis, “Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient,” Biochimica et Biophysica Acta—Biomembranes, vol. 857, no. 1, pp. 123–126, 1986. View at Publisher · View at Google Scholar · View at Scopus
  31. S. H. Hwang, Y. Maitani, X. Qi, K. Takayama, and T. Nagai, “Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods,” International Journal of Pharmaceutics, vol. 179, no. 1, pp. 85–95, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. E. M. Bolotin, R. Cohen, L. K. Bar et al., “Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes,” Journal of Liposome Research, vol. 4, no. 1, pp. 455–479, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Jesorka and O. Orwar, “Liposomes: technologies and analytical applications,” Annual Review of Analytical Chemistry, vol. 1, no. 1, pp. 801–832, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Lasic, Liposomes: From Physics to Applications, Elsevier, Amsterdam, The Netherlands, 1993.
  35. V. P. Torchilin, “Recent advances with liposomes as pharmaceutical carriers,” Nature Reviews Drug Discovery, vol. 4, no. 2, pp. 145–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Svetina, “Shape behavior of lipid vesicles as the basis of some cellular processes,” Anatomical Record, vol. 268, no. 3, pp. 215–225, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Tros de Ilarduya, Y. Sun, and N. Düzgüneş, “Gene delivery by lipoplexes and polyplexes,” European Journal of Pharmaceutical Sciences, vol. 40, no. 3, pp. 159–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Koltover, T. Salditt, and C. Safinya, “Phase diagram, stability, and overcharging of lamellar cationic lipid- DNA self-assembled complexes,” Biophysical Journal, vol. 77, no. 2, pp. 915–924, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Sternberg, “New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy,” FEBS Letters, vol. 356, no. 2-3, pp. 361–366, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Koltover, T. Salditt, J. O. Rädler, and C. R. Safinya, “An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery,” Science, vol. 281, no. 5373, pp. 78–81, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. J. O. Rädler, I. Koltover, T. Salditt, and C. R. Safinya, “Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes,” Science, vol. 275, no. 5301, pp. 810–814, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Gustafsson, G. Arvidson, G. Karlsson, and M. Almgren, “Complexes between cationic liposomes and DNA visualized by cryo-TEM,” Biochimica et Biophysica Acta—Biomembranes, vol. 1235, no. 2, pp. 305–312, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. J. N. Israelachvili, Intermolecular and Surface Forces, Academic Press, London, UK, 2nd edition, 1991.
  44. V. P. Torchilin, “Liposomes as targetable drug carriers,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 2, no. 1, pp. 65–115, 1985. View at Google Scholar · View at Scopus
  45. A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang, “Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes,” The FEBS Letters, vol. 268, no. 1, pp. 235–237, 1990. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Blume and G. Cevc, “Molecular mechanism of the lipid vesicle longevity in vivo,” Biochimica et Biophysica Acta: Biomembranes, vol. 1146, no. 2, pp. 157–168, 1993. View at Publisher · View at Google Scholar · View at Scopus
  47. A. A. Gabizon, “Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy,” Cancer Investigation, vol. 19, no. 4, pp. 424–436, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Martin and D. Lasic, Eds., Stealth Liposomes, CRC Press, Boca Raton, Fla, USA, 1995.
  49. V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov et al., “Poly( ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity,” Biochimica et Biophysica Acta, vol. 1195, no. 1, pp. 11–20, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. V. P. Torchilin and V. S. Trubetskoy, “Which polymers can make nanoparticulate drug carriers long-circulating?” Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 141–155, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. T. M. Allen and C. Hansen, “Pharmacokinetics of stealth versus conventional liposomes: effect of dose,” Biochimica et Biophysica Acta—Biomembranes, vol. 1068, no. 2, pp. 133–141, 1991. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Zabner, A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh, “Cellular and molecular barriers to gene transfer by a cationic lipid,” Journal of Biological Chemistry, vol. 270, no. 32, pp. 18997–19007, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. M. E. Dowty, P. Williams, G. Zhang, J. E. Hagstrom, and J. A. Wolff, “Plasmid DNA entry into postmitotic nuclei of primary rat myotubes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4572–4576, 1995. View at Google Scholar · View at Scopus
  54. P. Hug and R. G. Sleight, “Liposomes for the transformation of eukaryotic cells,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1097, no. 1, pp. 1–17, 1991. View at Publisher · View at Google Scholar · View at Scopus
  55. J. A. Wolff, R. W. Malone, P. Williams, G. Acsadi, A. Jani, and P. L. Felgner, “Direct gene transfer into mouse muscle in vivo,” Science, vol. 247, no. 4949, pp. 1465–1468, 1990. View at Publisher · View at Google Scholar · View at Scopus
  56. J. A. Wolff, M. E. Dowty, S. Jiao et al., “Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle,” Journal of Cell Science, vol. 103, no. 4, pp. 1249–1259, 1992. View at Google Scholar · View at Scopus
  57. M. Yoshida, R. I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida, “Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system,” Pharmaceutical Research, vol. 13, no. 4, pp. 599–603, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. M. A. Hickman, R. W. Malone, K. Lehmann-Bruinsma et al., “Gene expression following direct injection of DNA into liver,” Human Gene Therapy, vol. 5, no. 12, pp. 1477–1483, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. M. van Borssum-Waalkes, M. van Galen, H. Morselt, B. Sternberg, and G. L. Scherphof, “In vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-29-deox-yuridine and its diacylated derivatives,” Biochimica et Biophysica Acta, vol. 1148, no. 1, pp. 161–172, 1993. View at Google Scholar
  60. O. Zelphati, E. Wagner, and L. Leserman, “Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes,” Antiviral Research, vol. 25, no. 1, pp. 13–25, 1994. View at Publisher · View at Google Scholar · View at Scopus
  61. L. D. Mayer, T. M. Madden, M. B. Bally, and P. R. Cullis, “pH gradient-mediated drug entrapment in liposomes,” in Liposome Technology, G. Gregoriadis, Ed., vol. 2, CRC Press, Boca Raton, Fla, USA, 2nd edition, 1993. View at Google Scholar
  62. P. L. Felgner and G. M. Ringold, “Cationic liposome-mediated transfection,” Nature, vol. 337, no. 6205, pp. 387–388, 1989. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Leventis and J. R. Silvius, “Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles,” Biochimica et Biophysica Acta: Biomembranes, vol. 1023, no. 1, pp. 124–132, 1990. View at Publisher · View at Google Scholar · View at Scopus
  64. J. P. Behr, B. Demeneix, J. P. Loeffler, and J. Perez-Mutul, “Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 18, pp. 6982–6986, 1989. View at Google Scholar · View at Scopus
  65. I. Jääskeläinen, J. Mönkkönen, and A. Urtti, “Oligonucleotidecationic lipid interactions: a physicochemical study,” Biochimica et Biophysica Acta, vol. 1195, no. 1, pp. 115–123, 1994. View at Google Scholar
  66. J. Zabner, A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh, “Cellular and molecular barriers to gene transfer by a cationic lipid,” The Journal of Biological Chemistry, vol. 270, no. 32, pp. 18997–19007, 1995. View at Publisher · View at Google Scholar · View at Scopus
  67. I. Jääskeläinen, B. Sternberg, J. Mönkkönen, and A. Urtti, “Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides,” International Journal of Pharmaceutical, vol. 167, no. 1-2, pp. 191–203, 1998. View at Google Scholar
  68. G. J. Nabel, E. G. Nabel, Z. Yang et al., “Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11307–11311, 1993. View at Google Scholar · View at Scopus
  69. O. Boussif, F. LezoualC'H, M. A. Zanta et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7297–7301, 1995. View at Publisher · View at Google Scholar · View at Scopus
  70. M. X. Tang, C. T. Redemann, and F. C. Szoka Jr., “In vitro gene delivery by degraded polyamidoamine dendrimers,” Bioconjugate Chemistry, vol. 7, no. 6, pp. 703–714, 1996. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Haensler and F. C. Szoka Jr., “Polyamidoamine cascade polymers mediate efficient transfection of cells in culture,” Bioconjugate Chemistry, vol. 4, no. 5, pp. 372–379, 1993. View at Publisher · View at Google Scholar · View at Scopus
  72. M. X. Tang and F. C. Szoka, “The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes,” Gene Therapy, vol. 4, no. 8, pp. 823–832, 1997. View at Google Scholar · View at Scopus
  73. D. Needham, T. J. McIntosh, and D. D. Lasic, “Repulsive interactions and mechanical stability of polymer-grafted lipid membranes,” Biochimica et Biophysica Acta, vol. 1108, no. 1, pp. 40–48, 1992. View at Publisher · View at Google Scholar · View at Scopus
  74. M. DeCastro, Y. Saijoh, and G. C. Schoenwolf, “Optimized cationic lipid-based gene delivery reagents for use in developing vertebrate embryos,” Developmental Dynamics, vol. 235, no. 8, pp. 2210–2219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Shi, L. Wasungu, A. Nomden et al., “Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions,” Biochemical Journal, vol. 366, no. 1, pp. 333–341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Maeda, T. Sawa, and T. Konno, “Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS,” Journal of Controlled Release, vol. 74, no. 1–3, pp. 47–61, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Zalipsky, M. Qazen, J. A. Walker II, N. Mullah, Y. P. Quinn, and S. K. Huang, “New detachable poly(ethylene glycol) conjugates: Cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine,” Bioconjugate Chemistry, vol. 10, no. 5, pp. 703–707, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. Z. Symon, A. Peyser, D. Tzemach et al., “Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes,” Cancer, vol. 86, no. 1, pp. 72–78, 1999. View at Google Scholar
  79. A. T. Perez, G. H. Domenech, C. Frankel, and C. L. Vogel, “Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience,” Cancer Investigation, vol. 20, supplement 2, pp. 22–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. J. A. O'Shaughnessy, “Pegylated liposomal doxorubicin in the treatment of breast cancer,” Clinical Breast Cancer, vol. 4, no. 5, pp. 318–328, 2003. View at Google Scholar · View at Scopus
  81. M. Schwonzen, C. M. Kurbacher, and P. Mallmann, “Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer,” Anti-Cancer Drugs, vol. 11, no. 9, pp. 681–685, 2000. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Gonçalves, A. C. Braud, F. Viret et al., “Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors,” Anticancer Research, vol. 23, no. 4, pp. 3543–3548, 2003. View at Google Scholar · View at Scopus
  83. K. J. Harrington, C. Lewanski, A. D. Northcote et al., “Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck,” European Journal of Cancer, vol. 37, no. 16, pp. 2015–2022, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. S. R. D. Johnston and M. E. Gore, “Caelyx: phase II studies in ovarian cancer,” European Journal of Cancer, vol. 37, no. supplement 9, pp. S8–S14, 2001. View at Google Scholar · View at Scopus
  85. M. Schmidinger, C. Wenzel, G. J. Locker et al., “Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma,” The British Journal of Cancer, vol. 85, no. 12, pp. 1850–1852, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. U. Wollina, R. Dummer, N. H. Brockmeyer et al., “Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma,” Cancer, vol. 98, no. 5, pp. 993–1001, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. K. M. Skubitz, “Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma,” Cancer Investigation, vol. 21, no. 2, pp. 167–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. M. V. Seiden, F. Muggia, A. Astrow et al., “A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer,” Gynecologic Oncology, vol. 93, no. 1, pp. 229–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Sundar, T. K. Jha, C. P. Thakur, M. Mishra, V. P. Singh, and R. Buffels, “Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study,” Clinical Infectious Diseases, vol. 37, no. 6, pp. 800–804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. G. J. Grant, Y. Barenholz, E. M. Bolotin et al., “A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia,” Anesthesiology, vol. 101, no. 1, pp. 133–137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. D. E. Owens III and N. A. Peppas, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles,” International Journal of Pharmaceutics, vol. 307, no. 1, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. F. M. Veronese and G. Pasut, “PEGylation, successful approach to drug delivery,” Drug Discovery Today, vol. 10, no. 21, pp. 1451–1458, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. J. M. Harris, Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications, Plenum Press, New York, NY, USA, 1992.
  94. M. L. Adams, A. Lavasanifar, and G. S. Kwon, “Amphiphilic block copolymers for drug delivery,” Journal of Pharmaceutical Sciences, vol. 92, no. 7, pp. 1343–1355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. N. Kumar, M. N. V. Ravikumar, and A. J. Domb, “Biodegradable block copolymers,” Advanced Drug Delivery Reviews, vol. 53, no. 1, pp. 23–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Yokoyama, “Block copolymers as drug carriers,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 9, no. 3-4, pp. 213–248, 1992. View at Google Scholar · View at Scopus
  97. D. B. Shenoy and M. M. Amiji, “Poly(ethylene oxide)-modified poly(ε-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer,” International Journal of Pharmaceutics, vol. 293, no. 1-2, pp. 261–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. L. E. van Vlerken, T. K. Vyas, and M. M. Amiji, “Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery,” Pharmaceutical Research, vol. 24, no. 8, pp. 1405–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. United States Food and Drug Administration, http://www.fda.gov/Drugs/default.htm.
  100. T. Yamaoka, Y. Tabata, and Y. Ikada, “Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice,” Journal of Pharmaceutical Sciences, vol. 83, no. 4, pp. 601–606, 1994. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Monfardini, O. Schiavon, P. Caliceti, M. Morpurgo, J. M. Harris, and F. M. Veronese, “A branched monomethoxypoly(ethylene glycol) for protein modification,” Bioconjugate Chemistry, vol. 6, no. 1, pp. 62–69, 1995. View at Google Scholar · View at Scopus
  102. M. Hamidi, A. Azadi, and P. Rafiei, “Pharmacokinetic consequences of pegylation,” Drug Delivery, vol. 13, no. 6, pp. 399–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Gref, R. Gref, Y. Minamitake et al., “Biodegradable long-circulating polymeric nanospheres,” Science, vol. 263, no. 5153, pp. 1600–1603, 1994. View at Publisher · View at Google Scholar · View at Scopus
  104. R. Gref, A. Domb, P. Quellec et al., “The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres,” Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 215–233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  105. S. M. Moghimi, H. Hedeman, I. S. Muir, L. Illum, and S. S. Davis, “An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen,” Biochimica et Biophysica Acta, vol. 1157, no. 3, pp. 233–240, 1993. View at Google Scholar · View at Scopus
  106. S. M. Moghimi, A. C. Hunter, and J. C. Murray, “Long-circulating and target-specific nanoparticles: theory to practice,” Pharmacological Reviews, vol. 53, no. 2, pp. 283–318, 2001. View at Google Scholar · View at Scopus
  107. S. Mao, M. Neu, O. Germershaus et al., “Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes,” Bioconjugate Chemistry, vol. 17, no. 5, pp. 1209–1218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Kommareddy and M. Amiji, “Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice,” Journal of Pharmaceutical Sciences, vol. 96, no. 2, pp. 397–407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. B. Abdallah, A. Hassan, C. Benoist, D. Goula, J. P. Behr, and B. A. Demeneix, “A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine,” Human Gene Therapy, vol. 7, no. 16, pp. 1947–1954, 1996. View at Publisher · View at Google Scholar · View at Scopus
  110. M. P. Turunen, M. O. Hiltunen, M. Ruponen et al., “Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes,” Gene Therapy, vol. 6, no. 1, pp. 6–11, 1999. View at Publisher · View at Google Scholar · View at Scopus
  111. N. K. Egilmez, Y. Iwanuma, and R. B. Bankert, “Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer,” Biochemical and Biophysical Research Communications, vol. 221, no. 1, pp. 169–173, 1996. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Ylä-Herttuala, H. Sumuvuori, K. Karkola, M. Möttönen, and T. Nikkari, “Glycosaminoglycans in normal and atherosclerotic human coronary arteries,” Laboratory Investigation, vol. 54, no. 4, pp. 402–407, 1986. View at Google Scholar · View at Scopus
  113. T. N. Wight, D. K. Heinegård, and V. C. Hascall, “Proteoglycans; structure and function,” in Cell Biology of Extracellular Matrix, E. D. Hay, Ed., pp. 45–78, Plenum Press, New York, NY, USA, 1991. View at Google Scholar
  114. Y. Xu and F. C. Szoka Jr., “Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection,” Biochemistry, vol. 35, no. 18, pp. 5616–5623, 1996. View at Publisher · View at Google Scholar · View at Scopus
  115. J.-P. Behr, B. Demeneix, J.-P. Loeffler, and J. Perez-Mutul, “Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 18, pp. 6982–6986, 1989. View at Google Scholar · View at Scopus
  116. O. Boussif, F. Lezoualc'h, M. A. Zanta et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7297–7301, 1995. View at Publisher · View at Google Scholar · View at Scopus
  117. M. X. Tang and F. C. Szoka, “The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes,” Gene Therapy, vol. 4, no. 8, pp. 823–832, 1997. View at Publisher · View at Google Scholar · View at Scopus
  118. H. M. Temin, “Safety considerations in somatic gene therapy of human disease with retrovirus vectors,” Human Gene Therapy, vol. 1, no. 2, pp. 111–123, 1990. View at Publisher · View at Google Scholar · View at Scopus
  119. G. Y. Wu and C. H. Wu, “Receptor-mediated gene delivery and expression in vivo,” The Journal of Biological Chemistry, vol. 263, no. 29, pp. 14621–14624, 1988. View at Google Scholar · View at Scopus
  120. E. Wagner, M. Zenke, M. Cotten, H. Beug, and M. L. Birnstiel, “Transferrin-polycation conjugates as carriers for DNA uptake into cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 9, pp. 3410–3414, 1990. View at Publisher · View at Google Scholar · View at Scopus
  121. H. Farhood, R. Bottega, R. M. Epand, and L. Huang, “Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity,” Biochimica et Biophysica Acta—Biomembranes, vol. 1111, no. 2, pp. 239–246, 1992. View at Publisher · View at Google Scholar · View at Scopus
  122. N. J. Caplen, E. W. F. W. Alton, P. G. Middleton et al., “Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis,” Nature Medicine, vol. 1, no. 3, pp. 39–46, 1995. View at Google Scholar
  123. J. H. Felgner, R. Kumar, C. N. Sridhar et al., “Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations,” Journal of Biological Chemistry, vol. 269, no. 4, pp. 2550–2561, 1994. View at Google Scholar · View at Scopus
  124. M. S. Wadhwa, D. L. Knoell, A. P. Young, and K. G. Rice, “Targeted gene delivery with a low molecular weight glycopeptide carrier,” Bioconjugate Chemistry, vol. 6, no. 3, pp. 283–291, 1995. View at Google Scholar · View at Scopus
  125. G. Y. Wu and C. H. Wu, “Receptor-mediated in vitro gene transformation by a soluble DNA carrier system,” The Journal of Biological Chemistry, vol. 262, no. 10, pp. 4429–4432, 1987. View at Google Scholar · View at Scopus
  126. C. H. Wu, J. M. Wilson, and G. Y. Wu, “Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo,” The Journal of Biological Chemistry, vol. 264, no. 29, pp. 16985–16987, 1989. View at Google Scholar · View at Scopus
  127. H. C. Chiou, M. V. Tangco, S. M. Levine et al., “Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers,” Nucleic Acids Research, vol. 22, no. 24, pp. 5439–5446, 1994. View at Publisher · View at Google Scholar · View at Scopus
  128. X. Zhou, A. L. Klibanov, and L. Huang, “Lipophilic polylysines mediate efficient DNA transfection in mammalian cells,” Biochimica et Biophysica Acta, vol. 1065, no. 1, pp. 8–14, 1991. View at Publisher · View at Google Scholar · View at Scopus
  129. E. Wagner, C. Plank, K. Zatloukal, M. Cotten, and M. L. Birnstiel, “Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 17, pp. 7934–7938, 1992. View at Google Scholar · View at Scopus
  130. V. S. Trubetskoy, V. P. Torchilin, S. J. Kennel, and L. Huang, “Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells,” Bioconjugate Chemistry, vol. 3, no. 4, pp. 323–327, 1992. View at Publisher · View at Google Scholar · View at Scopus
  131. P. Midoux, C. Mendes, A. Legrand et al., “Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells,” Nucleic Acids Research, vol. 21, no. 4, pp. 871–878, 1993. View at Publisher · View at Google Scholar · View at Scopus
  132. D. Martinez-Fong, J. E. Mullersman, A. F. Purchio, J. Armendariz-Borunda, and A. Martinez-Hernandez, “Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery,” Hepatology, vol. 20, no. 6, pp. 1602–1608, 1994. View at Publisher · View at Google Scholar · View at Scopus
  133. P. Erbacher, M. Bousser, J. Raimond, M. Monsigny, P. Midoux, and A. C. Roche, “Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages,” Human Gene Therapy, vol. 7, no. 6, pp. 721–729, 1996. View at Publisher · View at Google Scholar · View at Scopus
  134. J. Kim, A. Maruyama, T. Akaike, and S. W. Kim, “In vitro gene expression on smooth muscle cells using a terplex delivery system,” Journal of Controlled Release, vol. 47, no. 1, pp. 51–59, 1997. View at Publisher · View at Google Scholar · View at Scopus
  135. M. A. Wolfert, E. H. Schacht, V. Toncheva, K. Ulbrich, O. Nazarova, and L. W. Seymour, “Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers,” Human Gene Therapy, vol. 7, no. 17, pp. 2123–2133, 1996. View at Publisher · View at Google Scholar · View at Scopus
  136. A. V. Kabanov, S. V. Vinogradov, Y. G. Suzdaltseva, and V. Y. Alakhov, “Water-soluble block polycations as carriers for oligonucleotide delivery,” Bioconjugate Chemistry, vol. 6, no. 6, pp. 639–643, 1995. View at Google Scholar · View at Scopus
  137. Y. H. Choi, F. Liu, J. Kim, Y. K. Choi, J. S. Park, and S. W. Kim, “Polyethylene glycol-grafted poly-L-lysine as polymeric gene carder,” Journal of Controlled Release, vol. 54, no. 1, pp. 39–48, 1998. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Ruponen, S. Ylä-Herttuala, and A. Urtti, “Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies,” Biochimica et Biophysica Acta: Biomembranes, vol. 1415, no. 2, pp. 331–341, 1999. View at Publisher · View at Google Scholar · View at Scopus
  139. T. Bronich, A. V. Kabanov, and L. A. Marky, “A thermodynamic characterization of the interaction of a cationic copolymer with DNA,” Journal of Physical Chemistry B, vol. 105, no. 25, pp. 6042–6050, 2001. View at Publisher · View at Google Scholar · View at Scopus
  140. S. Chesnoy and L. Huang, “DNA condensed by polycations and lipids for gene transfer,” S.T.P. Pharma Sciences, vol. 9, no. 1, pp. 5–12, 1999. View at Google Scholar · View at Scopus
  141. Y. Capan, B. H. Woo, S. Gebrekidan, S. Ahmed, and P. P. deLuca, “Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA,” Pharmaceutical Research, vol. 16, no. 4, pp. 509–513, 1999. View at Google Scholar · View at Scopus
  142. P. P. Karmali and A. Chaudhuri, “Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises,” Medicinal Research Reviews, vol. 27, no. 5, pp. 696–722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Mayhew and D. Papajadjopoulos, “Therapeutic applications of liposomes,” in Liposomes, M. J. Ostro, Ed., pp. 289–341, Marcel Dekker, New York, NY, USA, 1983. View at Google Scholar
  144. N. S. Templeton, “Cationic liposome-mediated gene delivery in vivo,” Bioscience Reports, vol. 22, no. 2, pp. 283–295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  145. X. Gao and L. Huang, “Potentiation of cationic liposome-mediated gene delivery by polycations,” Biochemistry, vol. 35, no. 3, pp. 1027–1036, 1996. View at Publisher · View at Google Scholar · View at Scopus
  146. F. L. Sorgi, S. Bhattacharya, and L. Huang, “Protamine sulfate enhances lipid-mediated gene transfer,” Gene Therapy, vol. 4, no. 9, pp. 961–968, 1997. View at Publisher · View at Google Scholar · View at Scopus
  147. R. J. Lee and L. Huang, “Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer,” Journal of Biological Chemistry, vol. 271, no. 14, pp. 8481–8487, 1996. View at Publisher · View at Google Scholar · View at Scopus
  148. L. K. Lee, C. L. Williams, D. Devore, and C. M. Roth, “Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides,” Biomacromolecules, vol. 7, no. 5, pp. 1502–1508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Li and L. Huang, “In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes,” Gene Therapy, vol. 4, no. 9, pp. 891–900, 1997. View at Publisher · View at Google Scholar · View at Scopus
  150. E. A. Murphy, A. J. Waring, S. M. Haynes, and K. J. Longmuir, “Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes,” Nucleic Acids Research, vol. 28, no. 15, pp. 2986–2992, 2000. View at Publisher · View at Google Scholar · View at Scopus
  151. E. A. Murphy, A. J. Waring, J. C. Murphy, R. C. Willson, and K. J. Longmuir, “Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipid,” Nucleic Acids Research, vol. 29, no. 17, pp. 3694–3704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  152. K. J. Longmuir, S. M. Haynes, M. E. Dickinson, J. C. Murphy, R. C. Willson, and A. J. Waring, “Optimization of a peptide/non-cationic lipid gene delivery system for effective microinjection into chicken embryo in vivo,” Molecular Therapy, vol. 4, no. 1, pp. 66–74, 2001. View at Publisher · View at Google Scholar · View at Scopus
  153. V. L. Makarov, Y. Hirose, and J. P. Langmore, “Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening,” Cell, vol. 88, no. 5, pp. 657–666, 1997. View at Publisher · View at Google Scholar · View at Scopus
  154. F. W. Smith and J. Feigon, “Quadruplex structure of Oxytricha telomeric DNA oligonucleotides,” Nature, vol. 356, no. 6365, pp. 164–168, 1992. View at Publisher · View at Google Scholar · View at Scopus
  155. J. T. Davis, “G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry,” Angewandte Chemie International Edition, vol. 43, no. 6, pp. 668–698, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. D. J. Patel, A. T. Phan, and V. Kuryavyi, “Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics,” Nucleic Acids Research, vol. 35, no. 22, pp. 7429–7455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  157. S. Neidle, “The structures of quadruplex nucleic acids and their drug complexes,” Current Opinion in Structural Biology, vol. 19, no. 3, pp. 239–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. M. Gellert, M. N. Lipsett, and D. R. Davies, “Helix formation by guanylic acid.,” Proceedings of the National Academy of Sciences of the United States of America, vol. 48, no. 12, pp. 2013–2018, 1962. View at Google Scholar · View at Scopus
  159. K. Paeschke, T. Simonsson, J. Postberg, D. Rhodes, and H. J. Lipps, “Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo,” Nature Structural and Molecular Biology, vol. 12, no. 10, pp. 847–854, 2005. View at Publisher · View at Google Scholar · View at Scopus
  160. N. Maizels, “Dynamic roles for G4 DNA in the biology of eukaryotic cells,” Nature Structural and Molecular Biology, vol. 13, no. 12, pp. 1055–1059, 2006. View at Publisher · View at Google Scholar · View at Scopus
  161. D. Sun, B. Thompson, B. E. Cathers et al., “Inhibition of human telomerase by a G-Quadruplex-Interactive compound,” Journal of Medicinal Chemistry, vol. 40, no. 14, pp. 2113–2116, 1997. View at Publisher · View at Google Scholar · View at Scopus
  162. J. L. Mergny and C. Helene, “G-quadruplex DNA: a target for drug design,” Nature Medicine, vol. 4, no. 12, pp. 1366–1367, 1998. View at Publisher · View at Google Scholar · View at Scopus
  163. A. M. Zahler, J. R. Williamson, T. R. Cech, and D. M. Prescott, “Inhibition of telomerase by G-quartet DNA structures,” Nature, vol. 350, no. 6320, pp. 718–720, 1991. View at Publisher · View at Google Scholar · View at Scopus
  164. L. Oganesian, I. K. Moon, T. M. Bryan, and M. B. Jarstfer, “Extension of G-quadruplex DNA by ciliate telomerase,” EMBO Journal, vol. 25, no. 5, pp. 1148–1159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  165. N. W. Kim, M. A. Piatyszek, K. R. Prowse et al., “Specific association of human telomerase activity with immortal cells and cancer,” Science, vol. 266, no. 5193, pp. 2011–2015, 1994. View at Google Scholar · View at Scopus
  166. S. B. Zimmerman and S. O. Trach, “Estimation of macromolecule concentrations and excluded volume effects for the cytoplasm of Escherichia coli,” Journal of Molecular Biology, vol. 222, no. 3, pp. 599–620, 1991. View at Google Scholar · View at Scopus
  167. R. J. Ellis and A. P. Minton, “Cell biology: join the crowd,” Nature, vol. 425, pp. 27–28, 2003. View at Google Scholar
  168. H. Zhou, G. Rivas, and A. P. Minton, “Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences,” Annual Review of Biophysics, vol. 37, pp. 375–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. D. Miyoshi and N. Sugimoto, “Molecular crowding effects on structure and stability of DNA,” Biochimie, vol. 90, no. 7, pp. 1040–1051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Miyoshi, A. Nakao, and N. Sugimoto, “Molecular crowding regulates the structural switch of the DNA G-quadruplex,” Biochemistry, vol. 41, no. 50, pp. 15017–15024, 2002. View at Publisher · View at Google Scholar · View at Scopus
  171. J. Li, J. J. Correia, L. Wang, J. O. Trent, and J. B. Chaires, “Not so crystal clear: the structure of the human telomere G-quadruplex in solution differs from that present in a crystal,” Nucleic Acids Research, vol. 33, no. 14, pp. 4649–4659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. D. Miyoshi, H. Karimata, and N. Sugimoto, “Hydration regulates thermodynamics of G-quadruplex formation under molecular crowding conditions,” Journal of the American Chemical Society, vol. 128, no. 24, pp. 7957–7963, 2006. View at Publisher · View at Google Scholar · View at Scopus
  173. M. Vorlíčková, K. Bednářová, I. Kejnovská, and J. Kypr, “Intramolecular and intermolecular guanine quadruplexes of DNA in aqueous salt and ethanol solutions,” Biopolymers, vol. 86, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  174. Y. Xue, Z. Kan, Q. Wang et al., “Human telomeric DNA forms parallel-stranded intramolecular G-quadruplex in K+ solution under molecular crowding condition,” Journal of the American Chemical Society, vol. 129, no. 36, pp. 11185–11191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  175. P. Balagurumoorthy, S. K. Brahmachari, D. Mohanty, M. Bansal, and V. Sasisekharan, “Hairpin and parallel quartet structures for telomeric sequences,” Nucleic Acids Research, vol. 20, no. 15, pp. 4061–4067, 1992. View at Publisher · View at Google Scholar · View at Scopus
  176. M. C. Miller, R. Buscaglia, J. B. Chaires, A. N. Lane, and J. O. Trent, “Hydration is a major determinant of the G-quadruplex stability and conformation of the human telomere 3′ sequence of d(AG 3(TTAG3)3),” Journal of the American Chemical Society, vol. 132, no. 48, pp. 17105–17107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  177. G. N. Parkinson, M. P. H. Lee, and S. Neidle, “Crystal structure of parallel quadruplexes from human telomeric DNA,” Nature, vol. 417, no. 6891, pp. 876–880, 2002. View at Publisher · View at Google Scholar · View at Scopus
  178. B. Heddi and A. T. Phan, “Structure of human telomeric DNA in crowded solution,” Journal of the American Chemical Society, vol. 133, no. 25, pp. 9824–9833, 2011. View at Publisher · View at Google Scholar · View at Scopus
  179. X. Liang, X. Li, J. Chang, Y. Duan, and Z. Li, “Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery,” Langmuir, vol. 29, no. 27, pp. 8683–8693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  180. K. von Gersdorff, N. N. Sanders, R. Vandenbroucke, S. C. de Smedt, E. Wagner, and M. Ogris, “The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type,” Molecular Therapy, vol. 14, no. 5, pp. 745–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  181. J. Rejman, A. Bragonzi, and M. Conese, “Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes,” Molecular Therapy, vol. 12, no. 3, pp. 468–474, 2005. View at Publisher · View at Google Scholar · View at Scopus
  182. M. A. E. M. van der Aa, U. S. Huth, S. Y. Häfele et al., “Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells,” Pharmaceutical Research, vol. 24, no. 8, pp. 1590–1598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  183. H. Hufnagel, P. Hakim, A. Lima, and F. Hollfelder, “Fluid phase endocytosis contributes to transfection of DNA by PEI-25,” Molecular Therapy, vol. 17, no. 8, pp. 1411–1417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. H. Hatakeyama, H. Akita, and H. Harashima, “The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors,” Biological and Pharmaceutical Bulletin, vol. 36, no. 6, pp. 892–899, 2013. View at Publisher · View at Google Scholar · View at Scopus
  185. C. S. Manno, V. R. Arruda, G. F. Pierce et al., “Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response,” Nature Medicine, vol. 12, no. 3, pp. 342–347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  186. F. Mingozzi, J. J. Meulenberg, D. J. Hui et al., “AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells,” Blood, vol. 114, no. 10, pp. 2077–2086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. A. R. Sharma, S. K. Kundu, J. S. Nam et al., “Next generation delivery system for proteins and genes of therapeutic purpose: why and how?” BioMed Research International, vol. 2014, Article ID 327950, 11 pages, 2014. View at Publisher · View at Google Scholar